XML 27 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues      
Premiums $ 49,397 $ 42,009 $ 42,034
Universal life and investment-type product policy fees 5,585 5,756 5,603
Net investment income 15,916 21,395 17,117
Other revenues 2,634 2,619 1,849
Net investment gains (losses) (1,262) 1,529 (110)
Net derivative gains (losses) (2,372) (2,228) 1,349
Total revenues 69,898 71,080 67,842
Expenses      
Policyholder benefits and claims 50,612 43,954 41,461
Interest credited to policyholder account balances 3,692 5,538 5,214
Policyholder dividends 701 876 1,090
Other expenses 12,034 12,586 13,150
Total expenses 67,039 62,954 60,915
Income (loss) before provision for income tax 2,859 8,126 6,927
Provision for income tax expense (benefit) 301 1,551 1,509
Net income (loss) 2,558 6,575 5,418
Less: Net income (loss) attributable to noncontrolling interests 19 21 11
Net income (loss) attributable to MetLife, Inc. 2,539 6,554 5,407
Less: Preferred stock dividends 185 195 202
Preferred stock redemption premium 0 6 14
Net income (loss) available to MetLife, Inc.’s common shareholders $ 2,354 $ 6,353 $ 5,191
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:      
Basic $ 2.93 $ 7.36 $ 5.72
Diluted $ 2.91 $ 7.31 $ 5.68